KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Change in Account Payables (2016 - 2019)

Alnylam Pharmaceuticals filings provide 11 years of Change in Account Payables readings, the most recent being -$30.1 million for Q3 2019.

  • On a quarterly basis, Change in Account Payables fell 431.18% to -$30.1 million in Q3 2019 year-over-year; TTM through Sep 2019 was $12.4 million, a 6.22% increase, with the full-year FY2018 number at $15.5 million, up 413.38% from a year prior.
  • Change in Account Payables hit -$30.1 million in Q3 2019 for Alnylam Pharmaceuticals, down from $43.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $43.5 million in Q2 2019 to a low of -$30.1 million in Q3 2019.
  • Median Change in Account Payables over the past 5 years was $347000.0 (2016), compared with a mean of $978631.6.
  • Biggest five-year swings in Change in Account Payables: plummeted 3289.34% in 2017 and later skyrocketed 6377.34% in 2019.
  • Alnylam Pharmaceuticals' Change in Account Payables stood at $2.6 million in 2015, then surged by 351.39% to $11.6 million in 2016, then increased by 6.68% to $12.3 million in 2017, then surged by 30.78% to $16.1 million in 2018, then tumbled by 286.56% to -$30.1 million in 2019.
  • The last three reported values for Change in Account Payables were -$30.1 million (Q3 2019), $43.5 million (Q2 2019), and -$17.1 million (Q1 2019) per Business Quant data.